Blood eosinophils measurement, as proxy for tissue eosinophils, has become an important
biomarker for exacerbation risk and response to inhaled corticosteroids (ICS) in Chronic …

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disorder and patients
respond differently to treatment. Blood eosinophils are a potential biomarker to stratify …

Background Chronic obstructive pulmonary disease (COPD) is characterised by progressive
airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which …

Background Eosinophilic airway inflammation characterizes a chronic obstructive pulmonary
disease (COPD) phenotype that requires more study. Objective To investigate the …

COPD is a significant cause of morbidity and mortality. In some patients with COPD,
eosinophils contribute to inflammation that promotes airway obstruction; approximately a …

Whether the level of circulating eosinophils in chronic obstructive pulmonary disease
(COPD) patients can predict the risk of exacerbations of COPD (ECOPD) or response to …

Purpose Blood eosinophil is a readily available biomarker to reflect the eosinophilic
inflammation in chronic obstructive pulmonary disease (COPD) patients, yet its association …

The heterogeneity of chronic obstructive pulmonary disease (COPD) creates many
diagnostic, prognostic, treatment and management challenges, as the pathogenesis of …

Background Growing evidence suggests that blood eosinophil count is associated with
patient responsiveness to inhaled corticosteroids (ICS). We performed post hoc predictive …

In patients with COPD, blood eosinophil counts can predict the effects of inhaled
corticosteroids (ICS) on exacerbation rates [1–4]. Blood eosinophil counts are now …